To Evaluate the Safety and Efficacy of Meplazumab in Treatment of COVID-19 Sequelae

meplazumab - Jiangsu Pacific Meinuoke Biopharmaceutical, Air Force Medical University

http://clinicaltrials.gov/ct2/show/NCT05813587

Apr 14, 2023